Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival
阅读量:
65
摘要:
Hypoxia inducible factors HIF1 and HIF2 are important proteins involved in the regulation of the transcription of a variety of genes related to erythropoiesis, glycolysis and angiogenesis. Hypoxic stimulation results in rapid increase of the HIF1 and 2 protein levels, as a consequence of a redox-sensitive stabilization. The HIFs enter the nucleus, heterodimerize with the HIF1 protein, and bind to DNA at the hypoxia response elements (HREs) of target genes. In this study we evaluated the immunohistochemical expression of these proteins in 108 tissue samples from non-small-cell lung cancer (NSCLC) and in normal lung tissues. Both proteins showed a mixed cytoplasmic/nuclear pattern of expression in cancer cells, tumoural vessels and tumour-infiltrating macrophages, as well as in areas of metaplasia, while normal lung components showed negative or very weak cytoplasmic staining. Positive HIF1 and HIF2 expression was noted in 68/108 (62%) and in 54/108 (50%) of cases respectively. Correlation analysis of HIF2 expression with HIF1 expression showed a significant association (P correlated with the expression of bek-bFGF receptor expression (P = 0.01), while HIF2 was associated with intense VEGF/KDR-activated vascularization (P = 0.002). HIF2 protein was less frequently expressed in cases with a medium microvessel density (MVD); a high rate of expression was noted in cases with both low and high MVD (P = 0.006). Analysis of overall survival showed that HIF2 expression was related to poor outcome (P = 0.008), even in the group of patients with low MVD (P = 0.009). HIF1 expression was marginally associated with poor prognosis (P = 0.08). In multivariate analysis HIF2 expression was an independent prognostic indicator (P = 0.006, t-ratio 2.7). We conclude that HIF1 and HIF2 overexpression is a common event in NSCLC, which is related to the up-regulation of various angiogenic factors and with poor prognosis. Targeting the HIF pathway may prove of importance in the treatment of NSCLC. © 2001 Cancer Research Campaign http://www.bjcancer.com
展开
DOI:
10.1054/bjoc.2001.2018
被引量:
年份:
2001
通过文献互助平台发起求助,成功后即可免费获取论文全文。
相似文献
参考文献
引证文献
来源期刊
引用走势
辅助模式
引用
文献可以批量引用啦~
欢迎点我试用!